Bawiec Christopher R, Hollender Peter J, Ornellas Sarah B, Schachtner Jessica N, Dahill-Fuchel Jacob F, Konecky Soren D, Allen John J B
Openwater, San Francisco, California, USA.
Department of Psychology, University of Arizona, Tucson, Arizona, USA.
J Ultrasound Med. 2025 Feb;44(2):239-261. doi: 10.1002/jum.16600. Epub 2024 Oct 24.
Transcranial low-intensity focused ultrasound (LIFU) offers unique opportunities for precisely neuromodulating small and/or deep targets within the human brain, which may be useful for treating psychiatric and neurological disorders. This article presents a novel ultrasound system that delivers focused ultrasound through the forehead to anterior brain targets and evaluates its safety and usability in a volunteer study.
The ultrasound system and workflow are described, including neuronavigation, LIFU planning, and ultrasound delivery components. Its capabilities are analyzed through simulations and experiments in water to establish its safe steering range. A cohort of 20 healthy volunteers received a LIFU protocol aimed at the anterior medial prefrontal cortex (amPFC), using imaging and questionnaires to screen for adverse effects. Additional development after the study also analyzes the effect of the skull and sinus cavities on delivered ultrasound energy.
Simulations and hydrophone readings agreed with <5% error, and the safe steering range was found to encompass a 1.8 cm × 2.5 cm × 2 cm volume centered at a depth 5 cm from the surface of the skin. There were no adverse effects evident on qualitative assessments, nor any signs of damage in susceptibility-weighted imaging scans. All participants tolerated the treatment well. The interface effectively enabled the users to complete the workflow with all participants. In particular, the amPFC of every participant was within the steering limits of the system. A post hoc analysis showed that "virtual fitting" could aid in steering the beams around subjects' sinuses.
The presented system safely delivered LIFU through the forehead while targeting the amPFC in all volunteers, and was well-tolerated. With the capabilities validated here and positive results of the study, this technology appears well-suited to explore LIFU's efficacy in clinical neuromodulation contexts.
经颅低强度聚焦超声(LIFU)为精确神经调节人脑内的小目标和/或深部目标提供了独特的机会,这可能对治疗精神疾病和神经疾病有用。本文介绍了一种新型超声系统,该系统通过前额向大脑前部目标发射聚焦超声,并在一项志愿者研究中评估其安全性和可用性。
描述了超声系统及其工作流程,包括神经导航、LIFU规划和超声发射组件。通过在水中的模拟和实验分析其性能,以确定其安全转向范围。一组20名健康志愿者接受了针对前内侧前额叶皮质(amPFC)的LIFU方案,使用成像和问卷来筛查不良反应。研究后的进一步开发还分析了颅骨和鼻窦腔对发射超声能量的影响。
模拟结果与水听器读数的误差小于5%,发现安全转向范围涵盖一个以距皮肤表面5 cm深度为中心的1.8 cm×2.5 cm×2 cm的体积。定性评估未发现明显不良反应,磁敏感加权成像扫描也未发现任何损伤迹象。所有参与者对治疗耐受性良好。该界面有效地使用户能够完成所有参与者的工作流程。特别是,每个参与者的amPFC都在系统的转向范围内。事后分析表明,“虚拟拟合”有助于引导波束绕过受试者的鼻窦。
所展示的系统在前额安全地发射LIFU,同时将所有志愿者的amPFC作为目标,且耐受性良好。鉴于此处验证的性能和研究的积极结果,这项技术似乎非常适合探索LIFU在临床神经调节中的疗效。